|
Originally published In Press as doi:10.1074/jbc.M105150200 on September 27, 2001
J. Biol. Chem., Vol. 276, Issue 50, 46770-46778, December 14, 2001
Dual Mode Recognition of Two Isoacceptor tRNAs by Mammalian
Mitochondrial Seryl-tRNA Synthetase*
Nobukazu
Shimada ,
Tsutomu
Suzuki §, and
Kimitsuna
Watanabe §¶
From the Department of Chemistry and Biotechnology,
Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo,
Bunkyo-ku, Tokyo 113-8656 and the § Department of Integrated
Biosciences, Graduate School of Frontier Sciences, University of
Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8583, Japan
Received for publication, June 5, 2001, and in revised form, September 21, 2001
 |
ABSTRACT |
Animal mitochondrial translation systems contain
two serine tRNAs, corresponding to the codons AGY (Y = U and C)
and UCN (N = U, C, A, and G), each possessing an unusual secondary
structure; tRNA (for AGY)
lacks the entire D arm, whereas
tRNA
(for UCN) has an unusual cloverleaf configuration. We previously
demonstrated that a single bovine mitochondrial seryl-tRNA synthetase
(mt SerRS) recognizes these topologically distinct isoacceptors having
no common sequence or structure. Recombinant mt SerRS clearly
footprinted at the T C loop of each isoacceptor, and kinetic studies
revealed that mt SerRS specifically recognized the T C loop sequence
in each isoacceptor. However, in the case of
tRNA , T C loop-D loop interaction was further required for recognition, suggesting that mt SerRS recognizes the two substrates by distinct mechanisms. mt SerRS could slightly but significantly misacylate mitochondrial tRNAGln, which has the same T C loop
sequence as
tRNA , implying that the fidelity of mitochondrial translation is maintained by kinetic discrimination of tRNAs in the network of
aminoacyl-tRNA synthetases.
 |
INTRODUCTION |
The fidelity of protein synthesis relies on the specific
attachment of amino acids to their cognate tRNA species. This process is catalyzed by aminoacyl-tRNA synthetase
(ARS),1 each species of which
discriminates with high selectivity among the many structurally similar
tRNAs and amino acids (1, 2). To avoid misacylation of tRNAs from any
of the 19 non-cognate groups, tRNAs possess identity elements within
their sequence or tertiary structure that are strictly recognized only
by the cognate synthetase. These identity elements are most commonly located in the anticodon and in the acceptor stem, particularly the
discriminator base at position 73 (2, 3). However, in the case of the
serine tRNA of Escherichia coli, several biochemical experiments have revealed that neither the anticodon
stem/loop nor the discriminator base is involved in
recognition (4, 5); instead, the E. coli
tRNASer identity elements are located in the characteristic
long extra arm (4-7). These findings conform well with analyses of the
crystallographic structures of seryl-tRNA synthetase
(SerRS)-tRNASer complexes from E. coli and
Thermus thermophilus (8-10), which indicate that the
N-terminal long helical domain of SerRS plays an important role in
recognizing the long extra arm and the T C loop of
tRNASer. In eukaryotic systems, cytoplasmic
tRNASer also has a long variable arm, and biochemical
studies of Saccharomyces cerevisiae and human
tRNAsSer have revealed that it contains the major identity
element of tRNASer (11-14). The recognition mechanism of
SerRS thus appears to be evolutionarily conserved in both prokaryote
and eukaryotic cytoplasm.
The mammalian mitochondrial (mt) translation system utilizes two
tRNASer species, one specific for codon AGY and the other
for UCN. Neither of these tRNAs has a long extra arm as a recognition
site for cytoplasmic SerRS (15). In addition, each possesses an unusual secondary structure; tRNA (for
codon AGY) lacks the entire D arm (16), whereas
tRNA (for codon UCN) has an
unusual cloverleaf configuration with an extended anticodon stem (17).
We previously demonstrated that the single mt SerRS recognizes these
distinct isoacceptors with almost the same activity (18). Additionally,
inspection of the primary sequences of several mt SerRSs revealed
differences between mammalian mt SerRS and its prokaryotic counterpart
in the N-terminal domain responsible for tRNA recognition, which are in
line with structural and recognition differences between the extra arms of mammalian mt and prokaryotic tRNAsSer. Because no other
tRNA investigated to date recognizes structurally different tRNA
isoacceptors, it is supposed that the recognition mechanism of
mammalian mt SerRS differs considerably from that of any other ARS.
Elucidating the mystery of how mammalian mt SerRS recognizes and
discriminates two isoacceptors with no common structure and sequence
from non-cognate tRNAs will not only extend our knowledge of the
recognition mechanism of ARS but also shed light on hidden aspects of
the mammalian mt translation system.
To investigate the recognition mechanism of mammalian mt SerRS, we
recombinantly expressed bovine mt SerRS in E. coli and performed a series of biochemical experiments using this enzyme and
several tRNA variants. On the basis of the results, we report here the
unique recognition mechanism of mammalian mt SerRS.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Phenylmethanesulfonyl fluoride was purchased from
Sigma; [14C]L-serine (5.59 GBq/mmol),
[32P]pCp, and a HiTrap chelating column were from
Amersham Pharmacia Biotech; the vector pET-19b was from Novagen;
nucleotide-specific RNases T1 and U2 were from
Amersham Pharmacia Biotech and Seikagaku Kogyo (Tokyo), respectively;
vectors pUC18 and pUC19 were from Takara; an anion-exchange tip was
from Qiagen; and a QuikChangeTM site-directed mutagenesis kit was from
Stratagene. Recombinant mt LeuRS was overproduced from an expression
vector kindly provided by Dr. L. L. Spremulli (University of North
Carolina, Chapel Hill, NC). Native bovine mt tRNAs were purified from
bovine mitochondria by selective hybridization using a solid phase DNA
probe as described by Wakita et al. (19).
Construction of Expression Plasmid--
cDNA for bovine mt
SerRS without an N-terminal peptide for mitochondrial importation was
amplified by PCR using synthetic primers; a forward primer
corresponding to the N-terminal end of mature mt SerRS
(atataccatgggccatcatcatcatcatcatcatggcagcgacgacgacgacaaggcaacggagaggcaggatcg) possessing an NcoI site, and a reverse primer for the
C-terminal end (cagccggatcctcagctcgaggcaggctgg) carrying a
BamHI site. The PCR product was cloned into pET-19b to
construct an expression vector for mature bovine mt SerRS with a
hexahistidine tag in the N-terminal region.
Expression and Purification of mt SerRS--
E. coli
BL21 (DE3) was used as a host for expression of the recombinant mt
SerRS. The culture conditions for overproducing cells were optimized to
maximum the expression of soluble enzyme. The transformant was cultured
in LB broth (100 µg/ml ampicillin) at 37 °C to an
A600 value of 0.6, and then induced by 10 µM isopropyl-1-thio- -D-galactopyranoside for 20 h at 28 °C. Cells harvested from 3 liters of LB broth
were resuspended in 40 ml of HT buffer (50 mM Hepes-KOH (pH
7.6), 100 mM KCl, 10 mM MgCl2, and
7 mM -mercaptoethanol) containing 0.2 mM
phenylmethanesulfonyl fluoride, 0.03% (w/v) egg white lysozyme, and
0.1% Triton X-100 and disrupted by 12-min sonication (repeated 1-s
bursts after 4-s cooling periods) at 100 watts and 0 °C. The homogenate was cleared by centrifugation at 100,000 × g for 60 min. The supernatant fraction (S100) was loaded
onto a nickel-charged HiTrap chelating column (5 ml). After washing out
nonbound proteins, the recombinant protein was eluted with a 60-ml
linear gradient from 0 to 350 mM imidazole in HT buffer. mt
SerRS was eluted in a fraction containing ~200 mM
imidazole. Protein concentrations were determined with a Bio-Rad
protein assay kit using bovine serum albumin as a standard. Glycerol
was added to pooled mt SerRS fractions at a final concentration of
30%, frozen quickly with liquid nitrogen, and stored at
70 °C.
Native PAGE and Gel Retardation Assay--
The mt
tRNASer-mt SerRS complex was formed as described by
Yokogawa et al. (18). Native PAGE was performed as described
by Hornung et al. (20); the gel was stained with Coomassie
Brilliant Blue and toluidine blue to analyze the components of the mt
tRNASer-mt SerRS complex. To determine the
Kd value by gel retardation assay, each mt
tRNASer was labeled with 32P at the 5' end.
Nonradioactive mt tRNASer was added to each labeled tRNA as
a carrier tRNA. Assays were performed by using five different
concentrations of tRNAsSer ranging from 0.25 to 5 µM (0.25, 1.0, 3, 4, and 5 µM) for
tRNA or from 0.25 to 3 µM (0.25, 0.5, 1.0, 2.0, and 3.0 µM) for
tRNA with a fixed concentration
(0.44 µM) of mt SerRS. The relative radioactivity of the
RNA band was quantified by a BAS-1000 imaging system (Fuji Photo Film).
The amounts of tRNASer-mt SerRS complexes were calculated
by subtracting the free tRNA counts from that of the whole count. The
Kd value for each native tRNASer was
obtained by Scatchard plots.
tRNA Footprinting with Ethylnitrosourea--
tRNA footprinting
using ethylnitrosourea was performed as described by Vlassov et
al. (21) with slight modification. mt tRNASer was
alkylated with or without mt SerRS at room temperature for 4 h in
a reaction mixture containing 5' end-labeled mt tRNASer
(~50,000 cpm/tube) with 1.5 µM cold carrier
tRNASer, 50 mM sodium cacodylate (pH 8.0), 10 mM MgCl2, and 0.11 volume of saturated
ethylnitrosourea (ethanol solution). The recombinant mt SerRS and
non-cognate mt LeuRS were added to the reaction mixture at final
concentrations of 1-5 and 5 µM, respectively. The
following experiment conducted after the alkylation was described
previously (21). Electrophoresis using 12% acrylamide, 7 M
urea gel was performed to analyze the footprint site of
tRNASer in the presence of mt SerRS. The band position was
assigned by comparison with partial RNase T1 and/or
U2 digests. The gel was exposed to an imaging plate,
followed by analysis using a Fuji BAS-1000 imaging analyzer.
Preparation of in Vitro Transcribed tRNAs--
Mitochondrial
tRNA variant genes were constructed on pUC18 under a T7 class III
promoter as described previously (22). The transcriptional template
harboring the T7 promoter and tRNA gene terminating at its
discriminator base (position 73) was amplified from the constructed
plasmid by PCR and transcribed to in vitro according to the
literature (23), except that the reaction mixture contained E. coli CCA, adding at 8 µg/1 ml. After the reaction, a small part
of the mixture was electrophoresed on 12% long denaturing polyacrylamide gel (40 cm × 20 cm × 0.35 mm) to check the
purity of the synthesized tRNA. All tRNA variants with the complete CCA sequence at the 3' end were synthesized with more than 70% purity. The
transcribed tRNA was extracted by phenol/chloroform treatment, applied
onto an anion-exchange tip (Qiagen), and then the complete tRNA band
was cut out from the 12% denaturing gel to separate it from the
adjacent minor bands. In this way, highly purified tRNA was obtained.
The 3' end of each tRNA was confirmed by thin layer chromatography
analysis of the 3'-terminal adenosine, which was labeled with
[32P]pCp (data not shown). In addition, the RNA sequences
of some variants were verified by Donis-Keller's enzymatic digestion
method (data not shown) (24). We finally succeeded in recovering about 0.2 A260 unit of pure tRNA/1-ml reaction mixture.
Preparation of tRNA Variants by in Vivo Expression--
To
prepare variants of mt tRNA
in vivo, the plasmid vector pUC19 carrying the tRNA gene
with the T7 promoter and terminator was constructed as reported
previously (25). The plasmids for the other
tRNA derivatives used were
prepared with a QuikChangeTM site-directed mutagenesis kit
(Stratagene). tRNA variants were expressed in E. coli strain
BL21 (DE3) according to Hayashi et al. (25). Expressed tRNA
was extracted from the cells as described (26) and purified by
electrophoresis on 8% polyacrylamide gel containing 7 M
urea and 20% formamide.
Aminoacylation Assay--
The aminoacylation reaction was
performed as described by Yokogawa et al. (18). The initial
rates of aminoacylation were ascertained by using six different tRNA
concentrations between 0.1 and 2 µM, determined,
respectively, according to the amount of each tRNA recovered. In each
case, mt SerRS was used at a fixed concentration optimized according to
the activity of each tRNA and ranging from 7.15 nM to 14.3 µM. Kinetic experiments gave reasonable Hanes-Woolf plots
for determining the kinetic parameters of Km and
kcat. All values are the averages of three independent determinations, which varied less than 15%. The
aminoacylation reaction for the minihelix tRNAsSer and
non-cognate mt tRNAs for Gln, Glu, and Tyr was carried out in 60 µl
of a reaction mixture containing 18 pmol of tRNA substrate and 9.5 µg
of mt SerRS. At each point, a 10-µl aliquot was withdrawn. We
calculated the quantity of each tRNA per A260
unit according to its length, namely 1800 pmol for
tRNA and its variants, 2000 pmol
for tRNA and 3600 pmol for the two
minihelix tRNAs. Other conditions were the same as those used to
determine the kinetic parameters.
 |
RESULTS |
Characterization of Recombinant mt SerRS--
Because it is almost
impossible to obtain sufficient native mt SerRS from bovine liver to
carry out a detailed investigation of the recognition mechanism,
recombinant mt SerRS with an N-terminal histidine tag was overexpressed
in E. coli cells. The optimized culture conditions for
maximum expression of the soluble protein are described under
"Experimental Procedures." As shown in Fig. 1, mt SerRS was purified almost
homogeneously by nickel-chelating chromatography. The yield was 8.4 mg
from 1 liter of the cell culture.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE analysis of purified bovine
recombinant mt SerRS. Lane 1, molecular weight markers
with their sizes indicated in kDa; lanes 2 and 3,
whole-cell extract and its soluble fraction from BL21 (DE3) carrying
pET-19b-mt SerRS after induction, respectively; lane 4, 1.7 µg of mt SerRS purified by nickel affinity chromatography. The gel
concentration was 9%, and the proteins were visualized by Coomassie
Brilliant Blue staining.
|
|
The overall structure of the recombinant mt SerRS was examined by
measuring the circular dichroism (CD) in the far-UV spectrum, which
exhibited CD troughs at 209 and 222 nm, typically indicative of a high
-helical content (data not shown). E. coli SerRS has a
similar CD spectrum. According to the online COILS algorithm for the
prediction of coiled coils from amino acid sequences
(dot.imgen.bcm.tmc.edu:9331/seq-search/struc-predict.html) (29), mt
SerRS has a single long -helix in the N-terminal region (residues
57-87), which could explain the CD spectral observation that mt SerRS
has a high helical content similar to that of E. coli SerRS.
In the crystal structure, E. coli SerRS is known to have two
long anti-parallel -helices in the N-terminal domain (residues
28-53 and 71-103) (27, 28), which were clearly predicted by the COILS algorithm.
In addition, the apparent molecular mass of mt SerRS in solution was
estimated by gel filtration column chromatography. The enzyme was
eluted mainly at 33 min, corresponding to a molecular mass of 109 kDa,
with minor peak at 37 min corresponding to 57 kDa (data not shown). As
the molecular mass of the enzyme has been calculated from its gene
sequence to be 56.3 kDa (18), mammalian mt SerRS seems to take a
homodimeric form, as is the case with prokaryotic SerRS (9, 27, 28,
30).
To establish whether the recombinant mt SerRS could specifically
recognize the two mt tRNAsSer, the serylation activity
kinetic parameters were determined using the native mt
tRNA and
tRNA as substrates. As shown in
Table I, the parameters of the
recombinant mt SerRS were almost identical to those of the native mt
SerRS. A gel retardation assay was performed to ascertain the complex formation of mt SerRS with each isoacceptor. The assay showed that mt
SerRS specifically formed binary complexes with the two serine
isoacceptors, whereas no complex was formed with non-cognate mt
tRNA (Fig.
2A). The dissociation constant
(Kd) for each tRNA substrate was determined by
means of Scatchard plots (Fig. 2B). The larger
Kd value of
tRNA (1 µM) is
indicative of a lower affinity toward mt SerRS. The difference in the
dissociation constants seems to reflect the different
Km values of the two substrates (Table I). In
addition, it appears that the x-intercept of each Scatchard plot approaches 1.8, suggesting that the two tRNAsSer bind
into one dimeric form of mt SerRS, although further structural analysis
is necessary to clarify the stoichiometry of the mt
SerRS-tRNASer complex.
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters in aminoacylation of bovine mitochondrial serine
tRNAs
Experimental conditions for aminoacylation are described under
"Experimental Procedures."
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 2.
Native PAGE analysis of complex formation
between bovine mt tRNAsSer and mt SerRS. A,
native PAGE analysis showing that mt SerRS formed a stable complex with
both mt tRNA and mt
tRNA . Lane 1, mt
tRNA (0.02 A260 unit); lane 2, mt SerRS (0.1 µg); lane 3, mt SerRS and 0.01 A260
unit of mt tRNA ; lane
4, mt SerRS and 0.01 A260 unit of mt
tRNA ; lane 5, mt SerRS
and 0.01 A260 unit of mt
tRNA . Lane 1 and
lanes 2-5 are separated because irrelevant lanes are
omitted, but the stains originate from the same gel. The gel was
stained with Coomassie Brilliant Blue and toluidine blue. B,
Scatchard plots of the complex band to determine the
Kd value for each mt tRNASer
complexed with mt SerRS. Complex formation was monitored with varying
concentrations of mt tRNASer (see "Experimental
Procedures"). The Kd value for each mt
tRNASer determined by the plot is displayed in each graph.
The values n and f represent the number of mt
tRNASer molecules binding to one dimer of mt SerRS and the
concentration of free mt tRNASer, respectively.
|
|
Because the foregoing observations strongly suggested that the
recombinant mt SerRS retained the original characteristics of the
native enzyme, the subsequent experiments were performed with this
recombinant enzyme.
mt SerRS Contact Sites on the Two Serine tRNAs--
tRNA
footprinting was carried out with ethylnitrosourea for both mt
tRNAsSer in the presence of mt SerRS, which strongly
protected mt tRNA against
alkylation by ethylnitrosourea at two specific regions, i.e.
phosphate positions 57-58 and 64-67 (Fig.
3A). mt
tRNA was also protected at similar
phosphate positions (55-59 and 65-67). No protection was observed in
the presence of human mt leucyl-tRNA synthetase (mt LeuRS), which was
used as a negative control for each mt tRNA (lanes 5 and
6 in Fig. 3, A and B, respectively). Moreover, no strong protection was found in the 5' region of mt tRNAsSer (data not shown). These results indicate that the
probable contact sites on both tRNAs are on the T C loop and at the
bottom of the acceptor stem. As shown in Fig. 3C, mammalian
mt SerRS contacts both tRNAs at similar positions though they have
different topologies.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 3.
Identification of footprinted sites on both
isoacceptors by mt SerRS using ethylnitrosourea. A,
footprinting of mt tRNA .
Lanes 1 and 2, control experiments in the absence
of reagent and enzyme, and in the absence of reagent only,
respectively; lane 3, alkylation in the absence of enzyme;
lanes 4 and 5, alkylation in the presence of mt
SerRS (5 µM) and human mt LeuRS (5 µM),
respectively; lane 6, partial ribonuclease T1
digest to assign the ladders. B, footprinting of mt
tRNA . Lane 1, control
incubation in the absence of reagent and enzyme; lane 2,
alkylation in the absence of enzyme; lanes 3, 4,
and 5, alkylation in the presence of mt SerRS at 1, 2, and 5 µM, respectively; lane 6, alkylation in the
presence of human mt LeuRS (5 µM); lanes 7 and
8, partial ribonuclease T1, and U2
digests, respectively. The numbers to the right
of the bands correspond to the base numbers for each tRNA. The
phosphate positions protected against alkylation in the presence of mt
SerRS are indicated by dashed lines.
C, secondary structures of mt
tRNA (upper) and
tRNA (lower); phosphate
positions strongly protected by mt SerRS are indicated by
arrowheads.
|
|
The crystal structure of T. thermophilus SerRS reveals
that Arg195 contacts positions 66-67 in the acceptor helix
of tRNASer, which is the same location as one of the mt
SerRS contact sites. Because Arg195 is conserved in
mammalian mt SerRS (18), it can be speculated that the contact site at
phosphate positions 64-67 may not be required for specific recognition
but would be involved in the essential interaction needed to arrange
the CCA terminus at the catalytic center of the enzyme.
tRNA Identity Elements
for mt SerRS--
Although tRNA footprinting clearly demonstrated that
mammalian mt SerRS contacts both isoacceptors similarly on the T C
loop and at the junction between the T C and acceptor stems, it was still unclear how mt SerRS specifically recognizes two tRNAs having no
common structure or sequence and identifies them among the 22 mt tRNAs.
To clarify the unique recognition mechanism of mt SerRS, the identity
elements of the respective isoacceptors needed to be determined.
To examine the recognition elements of mt
tRNA , we constructed several
variants carrying a mutation(s), mainly at bases in the T C loop,
which is one of the mt SerRS contact sites and is predicted to be
involved in tertiary interactions according to a previously proposed
model (31). The mutational variations are shown in Fig.
4A, and the kinetic parameters
are summarized in Table II. To achieve
efficient transcription by T7 RNA polymerase, the two terminal base
pairs, 1-72 and 2-71, were replaced with G·C pairs. The transcribed
tRNA with the canonical sequence
was shown to have a Km value 4 times higher than
that of the native tRNA from bovine liver. According to Hayashi
et al. (32), replacement of the two terminal base pairs
should have no effect on serylation activity, in which case the
relatively high Km value is apparently attributable to the lack of modified bases.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
tRNA variants used in this study based on
bovine mt tRNA
(A), bovine mt
tRNA
(B), and chicken mt
tRNA
(C). The two terminal base pairs in the
acceptor stems of bovine and chicken mt
tRNAs , 1-72 and 2-71, were
replaced with G·C pairs to achieve efficient in vitro
transcription (see "Results"). To facilitate the expression
of mt tRNA in E. coli
cells, five A·U base pairs in the acceptor stem of mt
tRNA , 2-71, 3-70, 4-69, 5-68,
and 6-67, were replaced with G·C pairs (see "Results").
Arrows indicate the substitutions, insertion, and deletions
made in this study. Broken lines in A
and B indicate the predicted tertiary base pairs proposed by
Watanabe et al. (31) and de Bruijn et al. (36),
respectively. The kinetic parameters for the tRNA variants of
bovine/chicken mt tRNAs and mt
tRNA are summarized in Tables II
and III, respectively.
|
|
We first examined the variants with mutations in the anticodon at
positions 34-36 and at the discriminator base (position 73), which are
recognition elements in most tRNAs. Replacement of the anticodon
sequence or the discriminator base caused no significant reduction in
serylation activity. As it was revealed that the A73G mutation could be
recognized more efficiently by the enzyme, mt SerRS apparently prefers
G73 as the discriminator base, which is in agreement with a previous
observation that a G73A mutation in
tRNA caused an ~3-fold reduction
in activity (33). It can thus be postulated that
tRNA possesses the less efficient
A73 as a discriminator base to balance the serine-accepting activities
of the two isoacceptors in vivo (Table I).
Next, to evaluate the effects of tertiary interactions in mt
tRNA on serylation activity, point mutations were introduced at bases involved in four possible
interactions (31): A15·U59, G18·U55, G19·C56, and U54·A58 (Fig.
4A). The A15·U59 interaction was shown not to be involved
in the activity because the individual mutations A15U and U59A as well
as the double mutation A15U,U59A all had relatively little effect in reducing the serylation activity (Table II). The variants G18U and U55G
had kcat/Km values that were
respectively reduced to 15 and 38% that of the wild type, which
probably resulted from destabilization of D loop-T C loop interaction
induced by the mutations. Severely reduced serylation activity was
induced by the mutations G19C and C56G, the relative
kcat/Km values being 2 orders
of magnitude lower (Table II). However, the variant carrying both
mutations (G19C and C56G) completely recovered its activity, suggesting
that the Watson-Crick base pair G19·C56 supporting D loop-T C loop
interaction is indispensable for recognition.
U54·A58 interaction in the T C loop was also revealed to be a
strong recognition element for serylation. The U54A and A58U mutants
exhibited significantly reduced serylation activity. Unlike the case of
the G19·C56 tertiary base pair, no restoration in the activity was
observed in the double mutant U54A,A58U, indicating that mt SerRS
probably recognizes the U54·A58 interaction not only structurally but
also sequence-specifically in the T C loop.
When compared with the canonical cloverleaf structure, mammalian mt
tRNA lacks six conserved residues, at positions 8, 16, 17, 21, 47, and 48, but contains one extra base
pair ( 26a·A43a) in the anticodon stem so as to form a
characteristic pseudo-cloverleaf structure (31). On the other hand,
chicken mt tRNA possesses the
canonical cloverleaf structure (34). Further, it has already been
demonstrated that the chicken tRNA can be serylated by the native
bovine mt SerRS.2 To
investigate the effect of the unusual cloverleaf structure of bovine mt
tRNA on its serylation activity,
we designed a variant mt tRNA possessing a canonical cloverleaf structure based on the chicken mt
tRNASer sequence. All the residues of the chicken mt
tRNASer apart from the D loop sequence were substituted for
those of bovine mt tRNA (Fig.
4C). As this variant showed no significant change in
serylation activity, it seems that the unusual cloverleaf structure of
mammalian mt tRNA does not
function as a key element for discrimination by mammalian mt SerRS.
Tiranti et al. reported the presence of a heteroplasmic
insertion at nucleotide position 7472 in human mt DNA (35). The insertion consequently adds one guanine at position 46.1 in the extra
arm of human mt tRNA , and the authors suggest that this mutation etiologically induces deafness by
altering the structure of the T C loop in mt
tRNA (35). In light of this, we
constructed a variant based on bovine mt
tRNA containing the same mutation (Fig. 4A; G46.1 insertion) and examined its serylation
activity. The mutation had little effect on the
kcat/Km value, indicating
that the deafness induced by the C7472 insertion is not caused by a
defect in the serine-accepting activity.
From the foregoing, it is concluded that mammalian mt SerRS recognizes
the mt tRNA T C loop
sequence-specifically and requires the D loop-T C loop interaction
sustained by the G19·C56 tertiary base pair for efficient
aminoacylation, whereas the characteristic pseudo-cloverleaf structure
per se is hardly involved in the serylation reaction.
tRNA Identity Elements
for mt SerRS--
Ueda et al. (33) previously examined the
recognition sites of mt tRNA using
partially purified enzyme, but the activity was too weak for the
kinetic parameters of several tRNA variants with low serine-accepting
activity to be determined. Therefore, we investigated the identity
elements for mt tRNA using the
recombinant enzyme with full activity. tRNA variants for mt
tRNA were prepared by the
in vivo expression system developed by Hayashi et al. (25), which allows variants to be easily purified in large quantities. Five A·U base pairs in the acceptor stem were replaced with G·C pairs (Fig. 4B) for efficient expression
as described (25). tRNA expressed
with the canonical sequence had a Km value 6 times
higher than that of native tRNA (Table
III). However, because Ueda et al. (33) previously revealed that the identity elements for mt
tRNA are not located in the
acceptor stem, we prepared a series of
tRNA variants using the same
expression system. The variations are shown in Fig. 4B, and
the kinetic parameters are summarized in Table III. We first examined
the serylation activity of the tRNA variant lacking a bulge (A43) in
the anticodon stem, which is a conserved structure among
mammalian mt tRNAs and is
considered to be involved in tertiary interaction with the T C loop
(16). This deletion hardly reduced the serylation activity. de Bruijn
and Klug (36) proposed a tertiary structural model of human and bovine
mt tRNAs with four possible
tertiary interactions, which are indicated by broken lines in Fig. 4B. Point mutations were introduced
at the bases involved to evaluate the effects of these postulated
tertiary interactions on serylation activity. The interactions
U8·A60A, and A9·U59 were revealed to have no relation
to the activity because the double mutation U8A,A9U did not
substantially reduce serylation (Table III). On the other hand, the
double mutation U59A,A60AU severely reduced the activity,
indicating that mt SerRS recognizes U59 and A60A
base-specifically. Similarly, the U10·A57 tertiary interaction was
not involved in serylation because the U10A variant showed only a
slight decrease in activity. To examine the U54·A58 interaction in
the T C loop, point mutations were introduced at positions 54 and 58. The U54A mutation reduced the
kcat/Km value by four-fifths,
but this was relatively little compared with the drastic loss of
activity by 2 orders of magnitude in the A58U variant (Table III).
Because no activity was restored by introducing the double mutation
U54A,A58U, which actually resulted in an even more severe decrease in
the kcat/Km value, it can be
assumed that the mt SerRS recognizes A58 base-specifically. With regard
to the individual effects of the two point mutations on serylation
activity, the theoretical activity derived by multiplying the
kcat/Km values of the
respective mutations should be in good agreement with the observed
value. Because the theoretical value for the double mutation (0.0039)
did in fact correspond well with the experimental value (0.0059), U54A
and A58U were shown to be mutations that individually reduced the
serylation activity. Finally, a point mutation was introduced at
position 57, which is one of the strong footprint sites; this A57U
mutation markedly reduced the activity.
From the foregoing, it can be concluded that mammalian mt SerRS
recognizes the T C loop sequence of mt
tRNA but, unlike the case of mt
tRNA recognition, it does not
recognize its tertiary structure. The major determinants, A57 and A58,
were shown to be the sites footprinted by the enzyme (Fig.
3A).
Dual Mode Recognition of the Two Isoacceptors by mt
SerRS--
Our findings on the identity elements of the two
structurally dissimilar isoaccepting tRNAs raised the possibility that
mammalian mt SerRS recognizes each tRNA by two distinct mechanisms. To
examine this notion, we constructed mt
tRNA variants in which the D arm
and/or T C loop were substituted by the D arm and T C loop
configurations of mt tRNA (Fig.
4A). As shown in Table II, the variant with the D arm
substitution (i.e. lacking a D arm, as is the case in mt
tRNA ) had a seriously decreased
kcat/Km value, whereas the activity was increased 3-fold by substituting the T C loop. The third
variant, carrying both the D arm and T C loop substitutions, showed
similar serylation activity to that of the canonical transcript. These
findings clearly indicated that the D loop-T C loop tertiary interactions are required for the serylation of mt
tRNA , whereas only the sequence of
the T C loop is important for the activity of mt
tRNA .
Aminoacylation of E. coli tRNAAla by alanyl-tRNA
synthetase (AlaRS) depends on a G3·U70 wobble base pair in the
acceptor stem (37). Understanding such a unique identity determinant
was greatly advanced by the demonstration that the minihelix variant,
composed only of the amino acid acceptor-T C helix, could be a good
substrate for AlaRS (38, 39). Therefore, to confirm the dual mode
recognition of the two tRNASer species, we similarly
prepared two minihelix tRNAsSer based on the two
isoacceptor tRNAs by connecting the acceptor stem and the T C stem
(Fig. 5A). As expected, the
tRNA minihelix exhibited
significant serylation activity (Fig. 5B, and Table III),
whereas the tRNA minihelix showed
none (Fig. 5B, and Table II).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Secondary structures of minihelix
tRNAsSer and their serylation activities.
A, secondary structures of minihelices derived from the
acceptor/T C helices of mt tRNA
and mt tRNAs , respectively.
B, serine accepting activities of minihelices derived from
tRNA ( ) and
tRNA ( ), and serylation of mt
tRNAs ( ) plotted as a positive
control. The kinetic parameters are shown in Tables II and III. The
experimental conditions are described under "Experimental
Procedures."
|
|
The above results clearly demonstrated that mammalian mt SerRS
recognizes the T C loop of tRNA
well in a sequence-specific manner. At the same time, the necessity of
dissimilar tertiary interactions for the recognition of the two mt
tRNAsSer by mt SerRS was underscored by this experiment.
Thus, there are both common and dissimilar features in the recognition
mechanisms of the single enzyme for the two substrates.
Misacylation of mt tRNAGln by mt SerRS--
Because
the T C loop sequence of each serine tRNA was shown to be important
for serylation, we searched mt tRNA sequences to discover whether a
T C loop sequence similar to that of either of the two serine tRNAs
exists among the 20 non-cognate mt tRNAs. Although no other bovine mt
tRNA has a sequence resembling the T C loop of mt
tRNA (40), three bovine mt tRNAs
(for Gln, Glu, and Tyr) have T C loop sequences the same as or
similar to that of mt tRNA ; the mt
tRNAGln sequence is identical, that of mt
tRNAGlu shows one nucleotide change (C56A), and
tRNATyr has two changes (C56U/U59C). Therefore, using
native mt tRNAs from bovine liver, we examined the mt SerRS
misacylation activity for each of these tRNAs. The results are shown in
Fig. 6 and Table IV. No activity was observed for the two
tRNAs with T C loop sequences similar to that of mt
tRNA (mt tRNAGlu and
mt tRNATyr).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Misacylation of non-cognate bovine mt
tRNAGln by mt SerRS. The serine-accepting
activities of mt tRNAs ( ), mt
tRNAGln ( ), mt tRNAGlu (×), and
mt tRNATyr ( ) were determined under the same
experimental conditions as those used for the plots in Fig.
5B. The kinetic parameters are shown in Table IV.
|
|
View this table:
[in this window]
[in a new window]
|
Table IV
Kinetic parameters for several bovine mitochondrial tRNAs and in vitro
transcripts
#, nucleotides in the T C loop differing from those of mt
tRNA at the same position are shown by outlined
letters. *, n.d., no activity was
detected.
|
|
To check the negative effects of these small changes in the T C loop
sequence on serylation activity, we constructed two
tRNA variants, C56A and C56U,U59C,
with T C loop sequences respectively corresponding to those of mt
tRNAGlu and mt tRNATyr (Fig. 4A).
These mutants showed 60-fold or more reductions in their
kcat/Km values (Table II),
indicating that the variant T C loop nucleotides in the mt tRNAs for
Glu and Tyr function as strong negative determinants in preventing
misacylation by mt SerRS, thereby maintaining the fidelity of
translation, i.e. mt SerRS seems to reject these non-cognate
mt tRNAs on the basis of their T C loop sequences. mt
tRNAGln, whose T C loop sequence is identical to that of
mt tRNA , was found to be
misacylated slightly but significantly by mt SerRS (Fig. 6), although
its kcat/Km value was 4 orders of magnitude smaller compared with that of mt
tRNA (Table IV). This finding is a
novel instance that appears to exist in the aminoacylation network to
maintain a high level of translational fidelity. Further experiments
were carried out to elucidate this notion.
Discrimination of mt
tRNA from Non-cognate mt
tRNAGln by mt SerRS--
As noted above,
although mt tRNAGln can be misacylated by mt SerRS, the
activity is kept at a low level even though mt tRNAGln
possesses the same T C loop sequence as mt
tRNA . To exclude the possible
influence of modified nucleotides, unmodified mt tRNAGln
was prepared by in vitro transcription. The data in Table IV show that this mt tRNAGln transcript still had serylation
activity 10-fold higher than that of the native tRNA. The misacylation
activity of the unmodified mt tRNAGln decreased ~42-fold
when compared with the activity of unmodified mt
tRNA .
We next investigated the sequence elements embedded in mt
tRNAGln to reduce misacylation by mt SerRS. We focused on
the G·U base pairs in the T C stems of mt tRNAGln and
mt tRNA , of which the former has one and the latter has two. It has been reported that a G·U base pair
in an RNA duplex distorts the conformation of the phosphodiester backbone (41). We therefore postulated that the number and/or location
of the wobble base pairs in the T C stem may have an effect on the
recognition of the T C loop by mt SerRS. To investigate this
possibility, several tRNAs
variants with mutations in their T C stems were constructed by
altering the number and/or location of the G·U base pairs. As shown
in Table V, substituting either or both
of the mt tRNA G·U base pairs
with G·C (v1, v2, and v3) had no significant effect on serylation.
However, the variant with a single G·U base pair at the same position
as that in mt tRNAGln (v4) showed a 15-fold reduction in
serylation activity. This result suggests that a single base pair,
G49·U64, in T C stem of mt tRNAGln acts as one of the
negative determinants for serylation by mt SerRS.
View this table:
[in this window]
[in a new window]
|
Table V
Kinetic parameters for tRNA transcripts
possessing mutations in the T C stem
#, nucleotides in the T C stem differing from those of mt
tRNA at the same position are shown by outlined
letters.
|
|
 |
DISCUSSION |
In general, isoacceptor tRNAs possess common sequences or
structures as identity elements for recognition by a cognate
aminoacyl-tRNA synthetase and to exclude recognition by non-cognate
synthetases. Thus, determining common features of isoacceptors provides
an important clue for predicting possible identity elements. In fact, a
number of identity elements of various tRNAs so far studied correspond
well to common sequences or structures, particularly the anticodon
sequence, discriminator base, and acceptor stem (15). However, in the
case of mammalian mitochondrial serine tRNAs, it is difficult to
extract common features of the two isoacceptors, mt
tRNA and mt
tRNA . In addition to there being
no apparent consensus sequence between these two tRNAs, structurally
each has a distinct topology. One speculation had been that two species
of SerRS might exist, one for each tRNA, as in the case of two
threonyl-tRNA synthetases in yeast mitochondria (42). However, we
demonstrated recently (18) that a single enzyme specifically recognizes
the two isoacceptors. How, then, does this mt SerRS recognize and
discriminate these two dissimilar tRNAs from non-cognate species?
The footprinting experiment with the mt SerRS-mt tRNASer
complex revealed that the enzyme contacts both tRNAs at nearly the same position; the T C loop and the bottom of the acceptor stem (Fig. 3).
The series of mutation studies clearly demonstrated that one of the
contact sites, the T C loop sequence, is important for recognition in
both cases. Herein can be found commonality in the recognition of the
two dissimilar tRNAs by mt SerRS. However, we next noted that mt SerRS
recognizes the T C loop in each tRNA by distinctive mechanisms,
because T C loop-D loop tertiary interaction is required for the
recognition of only mt
tRNA . The different
modes of recognition for the two substrates was accentuated by the fact
that the minihelix variant of mt
tRNA was a good substrate for mt
SerRS, whereas that of mt tRNA was
not (Fig. 5).
Crystallographic studies have revealed that E. coli SerRS
has a long helical arm consisting of an antiparallel, two-stranded coiled coil in the N-terminal domain (27, 28). In the crystal structure
of T. thermophilus SerRS complexed with tRNASer,
the N-terminal helical arm is tightly buried in the gulf between the
T C arm and the long extra arm of tRNASer with several
backbone contacts, whereas the C-terminal region of another subunit is
responsible for the catalytic activity (9). However, during the process
of mitochondrial evolution in the eukaryotic cell, prokaryotic
tRNAsSer would have lost their characteristic extra arms,
whereas the D arm was lost only in the case of mt
tRNA . Accordingly, the N-terminal
region of mt SerRS might have been obliged to recognize the T C loop
of mt tRNASer instead of the missing extra arm, because the
catalytic core in the C-terminal region is well conserved in mt SerRS
(18). Despite low homology in the N-terminal domain between mt SerRS and prokaryotic enzymes, a single, long helical arm was clearly predicted in the N-terminal region of bovine mt SerRS both by the CD
spectrum of the recombinant enzyme and computational analysis of the
helical structure using the COILS algorithm. It can be speculated that
the predicted N-terminal helical arm of mt SerRS may also be
responsible for mt tRNA recognition through interaction with the T C
loop. However, an investigation of the tertiary structure of the mt
SerRS-mt tRNASer complex is required to elucidate how the
N-terminal arm recognizes the T C loop of each tRNA. The molecular
basis of the precise mechanism of the dual mode recognition will be
clarified by such a structural study, which is now in progress in our laboratory.
The error rate of translation has been estimated to be
10 4 to 10 5 (43), which is of the same order
as misacylation (44), indicating that the fidelity of translation was
maintained by the accuracy of aminoacylation. In Candida
species, the codon CUG is known to be translated as serine instead of
leucine by the tRNA responsible
for this non-universal decoding (45, 46). We previously reported that
this tRNA can be aminoacylated not
only with serine, but also with leucine to some extent in vitro as well as in vivo (47). This was the first
report, and a unique instance, of a single tRNA in a natural organism
being acceptable to more than one species of amino acid. In the present study, we unexpectedly found that mt tRNAGln can be
slightly but significantly misacylated by mt SerRS (Table IV and Fig.
6), because mt tRNAGln has a T C loop sequence identical
to that of mt tRNA . Although
ambiguous specificity of mt aminoacyl-tRNA synthetase has been reported
in unilateral aminoacylation between heterologous tRNAs (48), it was a
surprise that mt SerRS cannot discriminate a cognate tRNA strictly even
inside the mitochondrion. The fact that the recognition of mt
tRNAGln by mt SerRS in vitro is 3700 times lower
than that of mt tRNA suggests that
kinetic discrimination arising from competition between mt SerRS and mt
GlnRS occurs in the mitochondrion to maintain the fidelity of mt
translation. It can be speculated that a reduction in the number of
tRNA species might impair the discriminatory ability of mt ARS. Our
finding raises the possibility that other mammalian mt aminoacyl-tRNA
synthetases may also misacylate non-cognate mt tRNAs, with the fidelity
of mt translation being maintained by the kinetic discrimination of mt
tRNAs in the network of ARSs. Further studies will certainly clarify
this notion and, as a result, deepen our understanding of the mammalian
mitochondrial translation system.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Linda L. Spremulli
(University of North Carolina, Chapel Hill, NC) for providing the
expression vector of human mt LeuRS. We thank Drs. Takashi Yokogawa
(Gifu University, Gifu, Japan), Hyota Himeno (Hirosaki
University, Aomori, Japan), Akiko Soma (RIKEN, Japan), and Takashi
Ohtsuki (University of Tokyo, Tokyo, Japan) for helpful discussions and
our colleagues Takehiro Yasukawa, Takeo Suzuki, Yukihide Tomari, and
Yoshihiro Shimizu (University of Tokyo, Tokyo, Japan) for gifts of
human mt LeuRS, bovine mt tRNAs, E. coli CCA-adding enzyme,
and E. coli SerRS, respectively.
 |
FOOTNOTES |
*
This work was supported by a grant-in-aid for scientific
research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology (Japan).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
81-471-36-3601; Fax: 81-471-36-3600; E-mail:
kw@kwl.t.u-tokyo.ac.jp.
Published, JBC Papers in Press, September 27, 2001, DOI 10.1074/jbc.M105150200
2
N. Nishioka, T. Yokogawa, and K. Watanabe,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ARS, aminoacyl-tRNA
synthetase;
SerRS, seryl-tRNA synthetase;
mt, mitochondrial;
tRNA , serine-specific tRNA having
the anticodon GCU corresponding to the codon AGY;
tRNA , serine-specific tRNA having
the anticodon UGA corresponding to the codon UCN;
tRNA , leucine-specific tRNA having
the anticodon UAA corresponding to the codon UUR;
AlaRS, alanyl-tRNA
synthetase;
mt LeuRS, mt leucyl-tRNA synthetase;
tRNAGln, glutamine-specific tRNA;
tRNAGlu, glutamic acid-specific
tRNA;
tRNATyr, tyrosine-specific tRNA;
PCR, polymerase
chain reaction;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Normanly, J.,
and Abelson, J.
(1989)
Annu. Rev. Biochem.
58,
1029-1049[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Schulman, L. H.
(1991)
Prog. Nucleic Acids Res. Mol. Biol.
41,
23-87[Medline]
[Order article via Infotrieve]
|
| 3.
|
Shimizu, M.,
Asahara, H.,
Tamura, K.,
Hasegawa, T.,
and Himeno, H.
(1992)
J. Mol. Evol.
35,
436-443[Medline]
[Order article via Infotrieve]
|
| 4.
|
Himeno, H.,
Hasegawa, T.,
Ueda, T.,
Watanabe, K.,
and Shimizu, M.
(1990)
Nucleic Acids Res.
18,
6815-6819[Abstract/Free Full Text]
|
| 5.
|
Sampson, J. R.,
and Saks, M. E.
(1993)
Nucleic Acids Res.
21,
4467-4475[Abstract/Free Full Text]
|
| 6.
|
Schatz, D.,
Leberman, R.,
and Eckstein, F.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
6132-6136[Abstract/Free Full Text]
|
| 7.
|
Asahara, H.,
Himeno, H.,
Tamura, K.,
Nameki, N.,
Hasegawa, T.,
and Shimizu, M.
(1994)
J. Mol. Biol.
236,
738-748[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Price, S.,
Cusack, S.,
Borel, F.,
Berthet-Colominas, C.,
and Leberman, R.
(1993)
FEBS Lett.
324,
167-170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Biou, V.,
Yaremchuk, A.,
Tukalo, M.,
and Cusack, S.
(1994)
Science
263,
1404-1410[Abstract/Free Full Text]
|
| 10.
|
Cusack, S.,
Yaremchuk, A.,
and Tukalo, M.
(1996)
EMBO J.
15,
2834-2842[Medline]
[Order article via Infotrieve]
|
| 11.
|
Achsel, T.,
and Gross, H. J.
(1993)
EMBO J.
12,
3333-3338[Medline]
[Order article via Infotrieve]
|
| 12.
|
Dock-Bregeon, A. C.,
Garcia, A.,
Giege, R.,
and Moras, D.
(1990)
Eur. J. Biochem.
188,
283-290[Medline]
[Order article via Infotrieve]
|
| 13.
|
Wu, X.-Q.,
and Gross, H. J.
(1993)
Nucleic Acids Res.
21,
5589-5594[Abstract/Free Full Text]
|
| 14.
|
Himeno, H.,
Yoshida, S.,
Soma, A.,
and Nishikawa, K.
(1997)
J. Mol. Biol.
268,
704-711[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Lenhard, B.,
Orellana, O.,
Ibba, M.,
and Weygand-Durasevic, I.
(1999)
Nucleic Acids Res.
27,
721-729[Abstract/Free Full Text]
|
| 16.
|
Steinberg, S.,
Gautheret, D.,
and Cedergren, R.
(1994)
J. Mol. Biol.
236,
982-989[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Yokogawa, T.,
Watanabe, Y.,
Kumazawa, Y.,
Ueda, T.,
Hirao, I.,
Miura, K.,
and Watanabe, K.
(1991)
Nucleic Acids Res.
19,
6101-6105[Abstract/Free Full Text]
|
| 18.
|
Yokogawa, T.,
Shimada, N.,
Takeuchi, N.,
Benkowski, L.,
Suzuki, T.,
Omori, A.,
Ueda, T.,
Nishikawa, K.,
Spremulli, L. L.,
and Watanabe, K.
(2000)
J. Biol. Chem.
275,
19913-19920[Abstract/Free Full Text]
|
| 19.
|
Wakita, K.,
Watanabe, Y.,
Yokogawa, T.,
Kumazawa, Y.,
Nakamura, S.,
Ueda, T.,
Watanabe, K.,
and Nishikawa, K.
(1994)
Nucleic Acids Res.
22,
347-353[Abstract/Free Full Text]
|
| 20.
|
Hornung, V.,
Hofmann, H. P.,
and Sprinzl, M.
(1998)
Biochemistry
37,
7260-7267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Vlassov, V. V.,
Kern, D.,
Giege, R.,
and Ebel, J. P.
(1981)
FEBS Lett.
123,
277-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Reyes, V. M.,
and Abelson, J.
(1987)
Anal. Biochem.
166,
90-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Sampson, J. R.,
and Uhlenbeck, O. C.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1033-1037[Abstract/Free Full Text]
|
| 24.
|
Donis-Keller, H.
(1980)
Nucleic Acids Res.
8,
3133-3142[Abstract/Free Full Text]
|
| 25.
|
Hayashi, I.,
Kawai, G.,
and Watanabe, K.
(1997)
Nucleic Acids Res.
25,
3503-3507[Abstract/Free Full Text]
|
| 26.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
|
| 27.
|
Oakley, M. G.,
and Kim, P. S.
(1997)
Biochemistry
36,
2544-2549[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Cusack, S.,
Berthet-Colominas, C.,
Hartlein, M.,
Nassar, N.,
and Leberman, R.
(1990)
Nature
347,
249-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Lupas, A.,
Van Dyke, M.,
and Stock, J.
(1991)
Science
252,
1162-1164[Free Full Text]
|
| 30.
|
Belrhali, H.,
Yaremchuk, A.,
Tukalo, M.,
Larsen, K.,
Berthet-Colominas, C.,
Leberman, R.,
Beijer, B.,
Sproat, B.,
Als-Nielsen, J.,
Grubel, G.,
Legrand, J.-F.,
Lehmann, M.,
and Cusack, S.
(1994)
Science
263,
1432-1436[Abstract/Free Full Text]
|
| 31.
|
Watanabe, Y.,
Kawai, G.,
Yokogawa, T.,
Hayashi, N.,
Kumazawa, Y.,
Ueda, T.,
Nishikawa, K.,
Hirao, I.,
Miura, K.,
and Watanabe, K.
(1994)
Nucleic Acids Res.
22,
5378-5384[Abstract/Free Full Text]
|
| 32.
|
Hayashi, I.,
Kawai, G.,
and Watanabe, K.
(1998)
J. Mol. Biol.
284,
57-69[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Ueda, T.,
Yotsumoto, Y.,
Ikeda, K.,
and Watanabe, K.
(1992)
Nucleic Acids Res.
20,
2217-2222[Abstract/Free Full Text]
|
| 34.
|
Nishioka, N.,
Yokogawa, T.,
Ueda, T.,
Watanabe, K.,
and Nishikawa, K.
(1994)
Nucleic Acids Symp. Ser.
31,
187-188
|
| 35.
|
Tiranti, V.,
Chariot, P.,
Carella, F.,
Toscano, A.,
Soliveri, P.,
Girlanda, P.,
Carrara, F.,
Fratta, G. M.,
Reid, F. M.,
Mariotti, C.,
and Zeviani, M.
(1995)
Hum. Mol. Genet.
4,
1421-1427[Abstract/Free Full Text]
|
| 36.
|
de Bruijn, M. H.,
and Klug, A.
(1983)
EMBO J.
2,
1309-1321[Medline]
[Order article via Infotrieve]
|
| 37.
|
Chang, K. Y.,
Varani, G.,
Bhattacharya, S.,
Choi, H.,
and McClain, W. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11764-11769[Abstract/Free Full Text]
|
| 38.
|
Francklyn, C.,
and Schimmel, P.
(1989)
Nature
337,
478-481[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
McClain, W. H.,
and Foss, K.
(1988)
Science
240,
793-796[Abstract/Free Full Text]
|
| 40.
|
Sprinzl, M.,
Horn, C.,
Brown, M.,
Ioudovitch, A.,
and Steinberg, S.
(1998)
Nucleic Acids Res.
26,
148-153[Abstract/Free Full Text]
|
| 41.
|
Ramos, A.,
and Varani, G.
(1997)
Nucleic Acids Res.
25,
2083-2090[Abstract/Free Full Text]
|
| 42.
|
Pape, L. K.,
Koerner, T. J.,
and Tzagoloff, A.
(1985)
J. Biol. Chem.
260,
15362-15370[Abstract/Free Full Text]
|
| 43.
|
Loftfield, R. B.,
and Vanderjagt, D.
(1972)
Biochem. J.
128,
1353-1356[Medline]
[Order article via Infotrieve]
|
| 44.
|
Parker, J.
(1989)
Microbiol. Rev.
53,
273-298[Free Full Text]
|
| 45.
|
Kawaguchi, Y.,
Honda, H.,
Taniguchi-Morimura, J.,
and Iwasaki, S.
(1989)
Nature
341,
164-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Ohama, T.,
Suzuki, T.,
Mori, M.,
Osawa, S.,
Ueda, T.,
Watanabe, K.,
and Nakase, T.
(1993)
Nucleic Acids Res.
21,
4039-4045[Abstract/Free Full Text]
|
| 47.
|
Suzuki, T.,
Ueda, T.,
and Watanabe, K.
(1997)
EMBO J.
16,
1122-1134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Kumazawa, Y.,
Himeno, H.,
Miura, K.,
and Watanabe, K.
(1991)
J. Biochem. (Tokyo)
109,
421-427[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Bilokapic, N. Ivic, V. Godinic-Mikulcic, I. Piantanida, N. Ban, and I. Weygand-Durasevic
Idiosyncratic Helix-Turn-Helix Motif in Methanosarcina barkeri Seryl-tRNA Synthetase Has a Critical Architectural Role
J. Biol. Chem.,
April 17, 2009;
284(16):
10706 - 10713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arita, T. Suematsu, A. Osanai, T. Inaba, H. Kamiya, K. Kita, M. Sisido, Y.-i. Watanabe, and T. Ohtsuki
An evolutionary 'intermediate state' of mitochondrial translation systems found in Trichinella species of parasitic nematodes: co-evolution of tRNA and EF-Tu
Nucleic Acids Res.,
October 6, 2006;
34(18):
5291 - 5299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mollers, K. Maniura-Weber, E. Kiseljakovic, M. Bust, A. Hayrapetyan, M. Jaksch, M. Helm, R. J. Wiesner, and J.-C. von Kleist-Retzow
A new mechanism for mtDNA pathogenesis: impairment of post-transcriptional maturation leads to severe depletion of mitochondrial tRNASer(UCN) caused by T7512C and G7497A point mutations
Nucleic Acids Res.,
September 30, 2005;
33(17):
5647 - 5658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Suematsu, A. Sato, M. Sakurai, K. Watanabe, and T. Ohtsuki
A unique tRNA recognition mechanism of Caenorhabditis elegans mitochondrial EF-Tu2
Nucleic Acids Res.,
August 19, 2005;
33(15):
4683 - 4691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Korencic, C. Polycarpo, I. Weygand-Durasevic, and D. Soll
Differential Modes of Transfer RNASer Recognition in Methanosarcina barkeri
J. Biol. Chem.,
November 19, 2004;
279(47):
48780 - 48786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Levinger, M. Morl, and C. Florentz
Mitochondrial tRNA 3' end metabolism and human disease
Nucleic Acids Res.,
October 11, 2004;
32(18):
5430 - 5441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. SISSLER, M. HELM, M. FRUGIER, R. GIEGE, and C. FLORENTZ
Aminoacylation properties of pathology-related human mitochondrial tRNALys variants
RNA,
May 1, 2004;
10(5):
841 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Rawlings, T. M. Collins, and R. Bieler
Changing identities: tRNA duplication and remolding within animal mitochondrial genomes
PNAS,
December 23, 2003;
100(26):
15700 - 15705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Toompuu, T. Yasukawa, T. Suzuki, T. Hakkinen, J. N. Spelbrink, K. Watanabe, and H. T. Jacobs
The 7472insC Mitochondrial DNA Mutation Impairs the Synthesis and Extent of Aminoacylation of tRNASer(UCN) but Not Its Structure or Rate of Turnover
J. Biol. Chem.,
June 14, 2002;
277(25):
22240 - 22250.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|